Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis

Abstract

BackgroundHyperprolinemia type 2 (HPII) is a rare autosomal recessive disorder of the proline metabolism, that affects the ALDH4A1 gene. So far only four different pathogenic mutations are known. The manifestation is mostly in neonatal age, in early infancy or early childhood.Case presentationThe 64-years female patient had a long history of abdominal pain, and episode of an acute neuritis. Ten years later she was admitted into the neurological intensive-care-unit with acute abdominal pain, multiple generalized epileptic seizures, a vertical gaze palsy accompanied by extensive lactic acidosis in serum 26.0\u2009mmol/l (reference: 0.55–2.2\u2009mmol/l) and CSF 12.01 mmol/l (reference: 1.12–2.47\u2009mmol/l). Due to repeated epileptic seizures and secondary complications a long-term sedation with a ventilation therapy over 20\u2009days was administered. A diagnostic work-up revealed up to 400-times increased prolin-level in urine CSF and blood. Furthermore, a low vitamin-B6 serum value was found, consistent with a HPII causing secondary pyridoxine deficiency and seizures. The ALDH4A1 gene sequencing confirmed two previously unknown compound heterozygous variants (ALDH4A1 gene (NM_003748.3) Intron 1: c.62\u2009+\u20091G\u2009>\u2009A - heterozygous and ALDH4A1 gene (NM_003748.3) Exon 5 c.349G\u2009>\u2009C, p.(Asp117His) - heterozygous). Under high-dose vitamin-B6 therapy no further seizures occurred.ConclusionWe describe two novel ALDH4A1-variants in an adult patient with hyperprolinemia type II causing secondary pyridoxine deficiency and seizures. Severe and potentially life-threatening course of this treatable disease emphasizes the importance of diagnostic vigilance and thorough laboratory work-up including gene analysis even in cases with atypical late manifestation.